1. Home
  2. AGEN vs BAER Comparison

AGEN vs BAER Comparison

Compare AGEN & BAER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.23

Market Cap

126.2M

Sector

Health Care

ML Signal

HOLD

Logo Bridger Aerospace Group Holdings Inc.

BAER

Bridger Aerospace Group Holdings Inc.

HOLD

Current Price

$2.67

Market Cap

101.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGEN
BAER
Founded
1994
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
126.2M
101.1M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
AGEN
BAER
Price
$3.23
$2.67
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$14.50
$5.25
AVG Volume (30 Days)
901.2K
920.7K
Earning Date
03-10-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$106,829,000.00
$129,868,000.00
Revenue This Year
$23.68
$24.95
Revenue Next Year
$23.17
$10.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
54.35
52 Week Low
$1.38
$1.02
52 Week High
$7.34
$3.63

Technical Indicators

Market Signals
Indicator
AGEN
BAER
Relative Strength Index (RSI) 40.39 68.89
Support Level $3.12 $2.62
Resistance Level $3.55 $3.10
Average True Range (ATR) 0.38 0.31
MACD -0.04 0.04
Stochastic Oscillator 6.57 66.21

Price Performance

Historical Comparison
AGEN
BAER

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

About BAER Bridger Aerospace Group Holdings Inc.

Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Bridger Aerospace provides aerial firefighting and wildfire management services to federal and state government agencies, including the United States Forest Service, across the nation. The company's portfolio is organized across two offerings: Fire Suppression, which Consists of deploying specialized Viking CL-415EAF (Super Scooper) aircraft to drop large amounts of water quickly and directly on wildfires, and Aerial Surveillance, providing aerial surveillance via manned aircraft for fire suppression aircraft.

Share on Social Networks: